Review

Small molecular therapeutic targets for neurodegenerative diseases.

Nagaraj Rangappa Riddhi Upadhyay Nathish Lakshman Sivasamy Ramasamy Murugan Sevanan A. Justin Subashchandrabose Chinnathambi

2026 · Advances in Protein Chemistry and Structural Biology · Vol 153, pp. 135-167 · 0 citations

Medicine

TL;DR

A deeper understanding of aging-associated molecular dysfunction is essential to design sustainable, disease-modifying therapeutics with cross-disease relevance.

DOI PubMed Semantic Scholar

View source

Similar papers

Open access Aug 2026

Emerging Advances in Neuropharmacology: Novel Therapeutic Targets for Neurodegenerative Disorders

Neurodegenerative diseases are a heterogeneous group of chronic and progressive disorders, which are characterized by selective neuronal destruction, synaptic malfunction and progressive cognitive and locomotor dysfunction. The major ones are Alzheimer disease, Parkinson disease, Huntington disease, and amyotrophic lat...

Nisha, Sumairah Qadir · Current Pharmaceutical Resea... · 0 citations

Review Jul 2026

Exploring shared genetic pathways and gene interplay in major neurodegenerative diseases: a comprehensive review.

This review examines the common genetic pathways, along with the interactions between genes of major neurodegenerative diseases, with a focus on the key genes, such as APOE, SNCA, MAPT, TARDBP, LRRK2 and HTT.

P. Pattnaik, S. Prusty, Sanghamitra Pati et al. · Gene · 0 citations

Review Open access Jul 2026

Precision therapeutics and innovative clinical trial design in neurodegenerative diseases.

This review summarizes emerging therapeutic approaches, including monoclonal antibodies targeting protein aggregation, immune-modulating and metabolic interventions, antisense oligonucleotides, gene replacement and genome-editing strategies, stem cell-based therapies, and neurosurgical delivery platforms and neuromodul...

A. Domínguez-García, J. C. Delgado-Uriarte, A. Cervantes-Arriaga · Revista de investigacion cli... · 0 citations

Review Jul 2026

Targeting Neuroinflammation and Neurodegeneration in Parkinson's Disease: Emerging Natural and Synthetic Therapeutic Strategies.

Natural bioactive compounds, gene-based therapies, stem cell-based therapies, stem cell-based therapies, and nanotechnology-assisted drug delivery systems are promising alternatives as suggested by recent advances and could help to more effectively and permanently manage PD.

S. Arbab, Hanif Ullah, Yanting Han et al. · Ageing Research Reviews · 0 citations

Review Aug 2026

Neuroinflammatory and molecular pathways in Alzheimer’s disease: mechanistic crosstalk and emerging therapeutic opportunities

Overall, this review makes a case for integrative, pathway-based therapeutic models, and multiple approaches may facilitate for drug development, biomarker identification and patient management in Alzheimer's disease.

Abhay Thakur, Rohit Sharma, Sneha Kumari et al. · InflammoPharmacology · 0 citations

Review Aug 2026

Multitargeted drug strategies for Alzheimer’s and Parkinson’s diseases

Recent advances in multitarget drug development for AD and PD targeting compounds targeting Aβ, BACE1, MAO-B, cholinesterases, metal-ion dyshomeostasis, oxidative stress, and inflammatory pathways are reviewed.

Azmatullah Khan, Abdullah Abdullah, Syeda Farwa Naqvi et al. · Zeitschrift für Naturforschu... · 0 citations